Component-resolved in vitro diagnosis in carrot allergy:: Does the use of recombinant carrot allergens improve the reliability of the diagnostic procedure?

被引:64
作者
Ballmer-Weber, BK
Wangorsch, A
Bohle, B
Kaul, S
Kündig, T
Fötisch, K
van Ree, R
Vieths, S
机构
[1] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland
[2] Paul Ehrlich Inst, Div Allergol, D-6070 Langen, Germany
[3] Med Univ Vienna, Dept Pathophysiol, Vienna, Austria
[4] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands
关键词
carrot allergy; component-resolved diagnosis; Dau c 1.0104; Dau c 1.0201; Dau c 4; immunotherapy; LTP; pollen-related food allergy;
D O I
10.1111/j.1365-2222.2005.02294.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background In Europe, pollen-related food allergy is the most frequent form of food allergy in adults. Reliability of current diagnostic procedures, however, is poor and therapeutic options are not available. Objectives In the present study, we created a panel of recombinant allergens from carrot and evaluated its potential in component-resolved in vitro diagnosis of carrot allergy. Methods Recombinant (r) Dau c 1.0104, Dau c 1.0201 and Dau c 4 were cloned by a polymerase chain reaction strategy, expressed in Escherichia coli and purified. Carrot lipid transfer protein (LTP) was expressed in the yeast Pichia pastoris. Sera from 40 carrot-allergic patients were investigated. Twenty-one birch pollen-allergic subjects with negative open provocation to carrot and 20 non-allergic subjects were included as controls. IgE binding to recombinant allergens as well as to cross-reactive carbohydrate determinants (CCD) was measured by ELISA. Cross-reactivity between Dau c 1 isoforms and Bet v 1 was assayed by ELISA inhibition. Results Biological activity of the recombinant carrot allergens was assessed by histamine release assay and peripheral blood mononuclear cells stimulation. Conclusions Ninety-eight percent of the carrot-allergic patients were positive to at least one recombinant allergen; 98% reacted to rDau c 1.0104, 65% to rDau c 1.0201, 38% to rDau c 4 and 20% had IgE against CCD. Specificity using the recombinant allergens was high when compared with non-allergic controls, but low compared with birch-sensitized subjects without carrot allergy. Sensitization to Dau c 1.0201, however, proved to be highly specific for clinically relevant sensitization. Inhibition assays indicated the absence of LTP in carrot root extract, and epitope diversity between Dau c 1.0104, Dau c 1.0201 and Bet v 1. Our panel of recombinant allergens from carrot can provide a standardized tool for in vitro diagnosis of carrot allergy, and for epitope studies.
引用
收藏
页码:970 / 978
页数:9
相关论文
共 35 条
[1]   DETERMINATION OF AMINO-SUGARS AND AMINO-ACIDS IN GLYCOCONJUGATES USING PRECOLUMN DERIVATIZATION WITH ORTHO-PHTHALALDEHYDE [J].
ALTMANN, F .
ANALYTICAL BIOCHEMISTRY, 1992, 204 (01) :215-219
[2]  
Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x
[3]   Immunological cross-reactivity between lipid transfer proteins from botanically unrelated plant-derived foods: a clinical study [J].
Asero, R ;
Mistrello, G ;
Roncarolo, D ;
Amato, S ;
Caldironi, G ;
Barocci, F ;
van Ree, R .
ALLERGY, 2002, 57 (10) :900-906
[4]   Lipid transfer protein: A pan-allergen in plant-derived foods that is highly resistant to pepsin digestion [J].
Asero, R ;
Mistrello, G ;
Roncarolo, D ;
de Vries, SC ;
Gautier, MF ;
Ciurana, LF ;
Verbeek, E ;
Mohammadi, T ;
Knul-Brettlova, V ;
Akkerdaas, JH ;
Bulder, I ;
Aalberse, RC ;
van Ree, R .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2000, 122 (01) :20-32
[5]   Carrot allergy:: Double-blinded, placebo-controlled food challenge and identification of allergens [J].
Ballmer-Weber, BK ;
Wüthrich, B ;
Wangorsch, A ;
Fötisch, K ;
Altmann, F ;
Vieths, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :301-307
[6]   Celery allergy confirmed by double-blind, placebo-controlled food challenge:: A clinical study in 32 subjects with a history of adverse reactions to celery root [J].
Ballmer-Weber, BK ;
Vieths, S ;
Lüttkopf, D ;
Heuschmann, P ;
Wüthrich, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (02) :373-378
[7]   Component-resolved diagnosis with recombinant allergens in patients with cherry allergy [J].
Ballmer-Weber, BK ;
Scheurer, S ;
Fritsche, P ;
Enrique, E ;
Cistero-Bahima, A ;
Haase, T ;
Wüthrich, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (01) :167-173
[8]   Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level [J].
Bohle, B ;
Radakovics, A ;
Jahn-Schmid, B ;
Hoffmann-Sommergruber, K ;
Fischer, GF ;
Ebner, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (12) :3303-3310
[9]   Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges [J].
Bolhaar, STHP ;
Tiemessen, MM ;
Zuidmeer, L ;
van Leeuwen, A ;
Hoffmann-Sommergruber, K ;
Bruijnzeel-Koomen, CAFM ;
Taams, LS ;
Knol, EF ;
van Hoffen, E ;
van Ree, R ;
Knulst, AC .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (05) :761-769
[10]   DIFFERENCES IN CLINICAL AND IMMUNOLOGICAL REACTIVITY OF PATIENTS ALLERGIC TO GRASS POLLENS AND TO MULTIPLE-POLLEN SPECIES .2. EFFICACY OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, SPECIFIC IMMUNOTHERAPY WITH STANDARDIZED EXTRACTS [J].
BOUSQUET, J ;
BECKER, WM ;
HEJJAOUI, A ;
CHANAL, I ;
LEBEL, B ;
DHIVERT, H ;
MICHEL, FB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (01) :43-53